Cytokines and acute neurodegeneration.
Rothwell
N J
NJ
School of Biological Sciences, University of Manchester, UK. Nancy.Rothwell@man.ac.uk
D000208:Acute Disease; D000818:Animals; D001925:Brain Damage, Chronic / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D001927:Brain Diseases / Q000503:physiopathology*; D020170:Caspase 1; D002561:Cerebrovascular Disorders / Q000150:complications / Q000188:drug therapy; D003546:Cysteine Endopeptidases / Q000502:physiology; D016207:Cytokines / Q000502:physiology*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000517:prevention & control; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1 / Q000633:toxicity; D009410:Nerve Degeneration / Q000502:physiology*; D009419:Nerve Tissue Proteins / Q000037:antagonists & inhibitors; D018696:Neuroprotective Agents / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use; D017470:Receptors, Glutamate / Q000187:drug effects; D012795:Sialoglycoproteins / Q000627:therapeutic use
D016207:Cytokines; C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1; D009419:Nerve Tissue Proteins; D018696:Neuroprotective Agents; D011480:Protease Inhibitors; D017470:Receptors, Glutamate; D012795:Sialoglycoproteins; D003546:Cysteine Endopeptidases; D020170:Caspase 1